Please try another search
For the nine months ended 30 September 2019,Medifirst Solutions Inc revenues increased from $16K to$52K. Net loss increased 100% to $1.5M. Revenues reflectProduct sales, net increase from $5K to $24K, ConsultingIncome increase from $12K to $27K. Higher net loss reflectsFV/Uls Adjust on Derivatives for Hedging decrease from$230K (income) to $471K (expense), Consulting fees increasefrom $133K to $331K (expense).
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0.03 | 0.03 | 0.01 |
Gross Profit | 0 | 0.02 | 0.02 | 0.01 |
Operating Income | -0.15 | -0.13 | -0.24 | -0.3 |
Net Income | -0.53 | -0.2 | -0.81 | -0.3 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 0.46 | 0.49 | 0.45 | 0.22 |
Total Liabilities | 1.95 | 2.03 | 2.23 | 1.46 |
Total Equity | -1.49 | -1.54 | -1.79 | -1.25 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.36 | -0.22 | -0.1 | -0.43 |
Cash From Investing Activities | 0 | 0 | 0 | 0 |
Cash From Financing Activities | 0.56 | 0.45 | 0.29 | 0.22 |
Net Change in Cash | 0.2 | 0.23 | 0.19 | -0.2 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review